Bioteque (4107) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 邦特

Bioteque (4107) reported revenue of NT$200.9 million for Oct 2026, +2.4% year on year and +2.7% from the previous month. Revenue for Jan–Oct 2026 was NT$1.92 billion (+8.6% year on year).

Revenue for Oct 2026 was a record high (previous high: May 2026, NT$197.3 million). →

Year-on-year revenue growth: 8 months in a row. →

In Oct 2026, it ranked No. 40 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$169.2 million24/10Nov 2024 NT$176.6 millionDec 2024 NT$158.5 millionJan 2025 NT$159.6 millionFeb 2025 NT$185.1 million25/02Mar 2025 NT$173.9 millionApr 2025 NT$182 millionMay 2025 NT$172.7 millionJun 2025 NT$175.7 million25/06Jul 2025 NT$177.9 millionAug 2025 NT$164.3 millionSep 2025 NT$177.1 millionOct 2025 NT$196.1 million25/10Nov 2025 NT$181.4 millionDec 2025 NT$189.6 millionJan 2026 NT$190.7 millionFeb 2026 NT$161.6 million26/02Mar 2026 NT$194.2 millionApr 2026 NT$193.7 millionMay 2026 NT$197.3 millionJun 2026 NT$197.2 million26/06Jul 2026 NT$192.9 millionAug 2026 NT$192.8 millionSep 2026 NT$195.5 millionOct 2026 NT$200.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$200.9 million+2.4%+2.7%
Sep 2026NT$195.5 million+10.4%+1.4%
Aug 2026NT$192.8 million+17.4%+0.0%
Jul 2026NT$192.9 million+8.4%-2.2%
Jun 2026NT$197.2 million+12.2%+0.0%
May 2026NT$197.3 million+14.3%+1.9%
Apr 2026NT$193.7 million+6.4%-0.3%
Mar 2026NT$194.2 million+11.7%+20.1%
Feb 2026NT$161.6 million-12.7%-15.2%
Jan 2026NT$190.7 million+19.5%+0.5%
Dec 2025NT$189.6 million+19.7%+4.5%
Nov 2025NT$181.4 million+2.7%-7.5%
Oct 2025NT$196.1 million+15.9%+10.7%
Sep 2025NT$177.1 million+1.7%+7.8%
Aug 2025NT$164.3 million-10.6%-7.6%
Jul 2025NT$177.9 million-8.9%+1.2%
Jun 2025NT$175.7 million+0.5%+1.7%
May 2025NT$172.7 million-0.8%-5.1%
Apr 2025NT$182 million+7.2%+4.7%
Mar 2025NT$173.9 million+2.3%-6.1%
Feb 2025NT$185.1 million+24.9%+16.0%
Jan 2025NT$159.6 million-10.4%+0.7%
Dec 2024NT$158.5 million-10.2%-10.2%
Nov 2024NT$176.6 million+3.7%+4.4%
Oct 2024NT$169.2 million-1.5%-2.9%

Jan–Oct 2026 cumulative: NT$1.92 billion (+8.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Bioteque vs PEC / Bioteque vs Lotus Pharm / Bioteque vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16